Parametric cost-effectiveness inference with skewed data

Comparing treatment effects while taking into account the associated costs is an important goal of cost-effectiveness analyses. Several cost-effectiveness measures have been proposed to quantify these comparisons, including the incremental cost-effectiveness ratio (ICER) and the incremental net benefit (INB). Various approaches have been proposed for constructing confidence intervals for ICER and INB, including parametric methods (e.g. based on the Delta method or on Fieller's method), nonparametric methods (e.g. various bootstrap methods), as well as Bayesian methods. Skewed data are usually the norm in cost-effectiveness analyses, and accurate parametric confidence intervals in this context are lacking. Confidence intervals for both ICER and INB are constructed using the concept of a generalized pivotal quantity, which can be derived for various combinations of normal, lognormal, and other skewed distributions for costs and effectiveness. The proposed methodology is straightforward in terms of computation and implementation even in the presence of covariates, and the resulting confidence intervals compared favorably with existing methods in a simulation study. The approach is illustrated using data from three randomized trials.

[1]  Andrew Briggs,et al.  Statistical Analysis of Cost-Effectiveness Data , 2006 .

[2]  A Briggs,et al.  The Distribution of Health Care Costs and Their Statistical Analysis for Economic Evaluation , 1998, Journal of health services research & policy.

[3]  Thomas Mathew,et al.  Comparing the means and variances of a bivariate log‐normal distribution , 2008, Statistics in medicine.

[4]  Thomas Mathew,et al.  Generalized p -values and generalized confidence regions for the multivariate Behrens-Fisher problem and MANOVA , 2004 .

[5]  E. B. Wilson,et al.  The Distribution of Chi-Square. , 1931, Proceedings of the National Academy of Sciences of the United States of America.

[6]  H. Iyer,et al.  Fiducial Generalized Confidence Intervals , 2006 .

[7]  Samaradasa Weerahandi Generalized inference in repeated measures : exact methods in MANOVA and mixed models , 2004 .

[8]  Samaradasa Weerahandi,et al.  Generalized Confidence Intervals , 1993 .

[9]  Simon G Thompson,et al.  How Sensitive Are Cost-Effectiveness Analyses to Choice of Parametric Distributions? , 2005, Medical decision making : an international journal of the Society for Medical Decision Making.

[10]  Anthony O'Hagan,et al.  Review of Statistical Methods for Analysing Healthcare Resources and Costs , 2010, Health economics.

[11]  Hongwei Zhao,et al.  A Study on Confidence Intervals for Incremental Cost‐Effectiveness Ratios , 2008, Biometrical journal. Biometrische Zeitschrift.

[12]  A A Stinnett,et al.  Net Health Benefits , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[13]  Generalized Confidence Intervals for Ratios of Regression Coefficients with Applications to Bioassays , 2009, Biometrical journal. Biometrische Zeitschrift.

[14]  Y. Tsai,et al.  The Impact of Outliers on Net-Benefit Regression Model in Cost-Effectiveness Analysis , 2013, PloS one.

[15]  A H Briggs,et al.  Constructing confidence intervals for cost-effectiveness ratios: an evaluation of parametric and non-parametric techniques using Monte Carlo simulation. , 1999, Statistics in medicine.

[16]  Anthony O'Hagan,et al.  Assessing and comparing costs: how robust are the bootstrap and methods based on asymptotic normality? , 2003, Health economics.

[17]  Dulal K. Bhaumik,et al.  Testing Parameters of a Gamma Distribution for Small Samples , 2009, Technometrics.

[18]  R. Grieve,et al.  Non-parametric methods for cost-effectiveness analysis: the central limit theorem and the bootstrap compared. , 2010, Health economics.

[19]  John C. Hershey,et al.  Carrier Screening for Cystic Fibrosis , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[20]  Hongwei Zhao,et al.  Cost-Effectiveness Analysis: A Proposal of New Reporting Standards in Statistical Analysis , 2014, Journal of biopharmaceutical statistics.

[21]  D Polsky,et al.  Confidence intervals for cost-effectiveness ratios: a comparison of four methods. , 1997, Health economics.

[22]  Robert Tibshirani,et al.  An Introduction to the Bootstrap , 1994 .

[23]  T. Mathew,et al.  Inferences on the means of lognormal distributions using generalized p-values and generalized confidence intervals , 2003 .

[24]  J. Gardiner,et al.  The effect of outliers on confidence interval procedures for cost‐effectiveness ratios , 2001, Statistics in medicine.

[25]  J. Heyse,et al.  Use of an angular transformation for ratio estimation in cost-effectiveness analysis. , 2000, Statistics in medicine.

[26]  Xiao-Hua Zhou,et al.  A simulation study to compare methods for constructing confidence intervals for the incremental cost-effectiveness ratio , 2007, Health Services and Outcomes Research Methodology.

[27]  G. R. Williams,et al.  Fieller's Interval and the Bootstrap-Fieller Interval for the Incremental Cost-Effectiveness Ratio , 2000, Health Services and Outcomes Research Methodology.

[28]  Gianluca Baio,et al.  Bayesian Methods in Health Economics , 2012 .

[29]  B J O'Brien,et al.  Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods , 2002, Statistical methods in medical research.

[30]  K. Krishnamoorthy,et al.  Normal-Based Methods for a Gamma Distribution , 2008, Technometrics.

[31]  Sam Weerahandi,et al.  Exact Statistical Methods for Data Analysis , 1998, Journal of the American Statistical Association.

[32]  E. C. Fieller SOME PROBLEMS IN INTERVAL ESTIMATION , 1954 .